DRL-17822

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDRL-17822
Drug Alias NameCZ0L-3DRL-17822
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkrainePolandItaly
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDr.Reddy's Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDr.Reddy's Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsHyperlipoproteinemia Type II

Other Information

ATC CodeN/A
Related LinksN/A